Correlation Between Tonix Pharmaceuticals and 747262AU7

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and 747262AU7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and 747262AU7 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and QVC 445 percent, you can compare the effects of market volatilities on Tonix Pharmaceuticals and 747262AU7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of 747262AU7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and 747262AU7.

Diversification Opportunities for Tonix Pharmaceuticals and 747262AU7

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tonix and 747262AU7 is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and QVC 445 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QVC 445 percent and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with 747262AU7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QVC 445 percent has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and 747262AU7 go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and 747262AU7

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to generate 13.05 times more return on investment than 747262AU7. However, Tonix Pharmaceuticals is 13.05 times more volatile than QVC 445 percent. It trades about 0.19 of its potential returns per unit of risk. QVC 445 percent is currently generating about -0.21 per unit of risk. If you would invest  19.00  in Tonix Pharmaceuticals Holding on October 9, 2024 and sell it today you would earn a total of  12.00  from holding Tonix Pharmaceuticals Holding or generate 63.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  QVC 445 percent

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
QVC 445 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days QVC 445 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for QVC 445 percent investors.

Tonix Pharmaceuticals and 747262AU7 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and 747262AU7

The main advantage of trading using opposite Tonix Pharmaceuticals and 747262AU7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, 747262AU7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 747262AU7 will offset losses from the drop in 747262AU7's long position.
The idea behind Tonix Pharmaceuticals Holding and QVC 445 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world